UBS raised the firm’s price target on Elanco (ELAN) to $25 from $19 and keeps a Buy rating on the shares. UBS favors Elanco into the print and foresees EBITDA upside, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- 3 Stocks That Technical Analysis Flags as Must-Buys Today
- Elanco upgraded to Overweight from Neutral at JPMorgan
- Elanco Animal Health: Promising Growth Driven by Innovation and Market Dynamics
- Elanco price target raised to $23 from $18 at Stifel
- Positive FDA Update on Elanco’s Zenrelia Supports Buy Rating